Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
Discover the advanced techniques and skilled craftsmanship behind every roll, ensuring exceptional softness and durability. See how precision and innovation come together to create a product designed ...